Prosecution Insights
Prosecution Insights
18 pending office actions • 14 art units • 16 examiners • 0 of 18 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (17%) |
| §103 only | 3 (17%) |
| §102 only | 1 (6%) |
| §112 only | 4 (22%) |
| Double-patenting + other | 1 (6%) |
| Multi-statute (no §101) | 6 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHNSON, KARA D | 2 | 69.1% | +24.6% |
| LU, CHENG | 2 | 53.7% | +66.2% |
| PARK, EVELYN GRACE | 1 | 53.5% | +46.0% |
| CHATTERJEE, JAYANTA | 1 | 47.4% | +76.9% |
| STOFFA, WYATT A | 1 | 79.5% | +23.1% |
| MOU, LIYUAN | 1 | 43.5% | +57.7% |
| SORKIN, DAVID L | 1 | 67.3% | +12.8% |
| STEPHENS, AMELIA CAROLE | 1 | 80.0% | +50.0% |
| KAUFMAN, CLAIRE M | 1 | 63.3% | +51.5% |
| GONZALES, JOSEPHINE MARIA | 1 | 27.4% | +37.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281977 | ANTI- ENOLASE 1 (ENO1) ANTIBODY AND APPLICATIONS THEREOF | STEPHENS, AMELIA CAROLE | 70d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17908585 | METHOD FOR NATURAL KILLER CELL EXPANSION | ROGERS, ERIC JASON | 78d overdue |
| 17918947 | OLIGONUCLEOTIDE CONJUGATES AND PREPARATION AND APPLICATIONS THEREOF | PUTTLITZ, KARL J | 8d |
| 18645166 | METHOD FOR PROMOTING GROWTH OF PLANTS | CHATTERJEE, JAYANTA | 33d |
| 18689852 | COMPOUNDS AND THEIR USES FOR TREATING NEURODEGENERATIVE DISEASE | MOU, LIYUAN | — |
| 18681077 | MICROFLUIDIC MIXER FOR ENHANCED THREE-DIMENSIONAL MIXING | SORKIN, DAVID L | — |
| 18267996 | CELL CULTURE SYSTEMS, METHODS AND USES THEREOF | GONZALES, JOSEPHINE MARIA | — |
| 18266882 | ANTAGONIST OF INTERLEUKIN-17B RECEPTOR (IL-17RB) AND USE THEREOF | BRADLEY, CHRISTINA | — |
| 18116952 | COMPOSITION AND METHOD FOR MODULATING FIBROBLAST GROWTH FACTOR RECEPTOR 3 ACTIVATION | RZECZYCKI, PHILLIP MATTHEW | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18645166 | METHOD FOR PROMOTING GROWTH OF PLANTS | CHATTERJEE, JAYANTA | 33d |
| 18281977 | ANTI- ENOLASE 1 (ENO1) ANTIBODY AND APPLICATIONS THEREOF | STEPHENS, AMELIA CAROLE | 70d |
| 18854965 | Non-Invasive Blood Glucose Prediction by Deduction Learning System | PARK, EVELYN GRACE | — |
| 18701598 | HIGH RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETER AND METHODS OF PRODUCING THE SAME | STOFFA, WYATT A | — |
| 18697799 | CELL CULTURE PLATFORMS, METHODS AND USES THEREOF | JOHNSON, KARA D | — |
| 18689852 | COMPOUNDS AND THEIR USES FOR TREATING NEURODEGENERATIVE DISEASE | MOU, LIYUAN | — |
| 18681077 | MICROFLUIDIC MIXER FOR ENHANCED THREE-DIMENSIONAL MIXING | SORKIN, DAVID L | — |
| 18272107 | RECOMBINANT POLYPEPTIDES, CONJUGATES COMPRISING THE SAME, AND USES THEREOF | KAUFMAN, CLAIRE M | — |
| Art Unit | Apps |
|---|---|
| 1642 | 2 |
| 1662 | 1 |
| 2881 | 1 |
| 1628 | 1 |
| 1645 | 1 |
| 1674 | 1 |
| 1631 | 1 |
| 1654 | 1 |
| 1625 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18854965 | Non-Invasive Blood Glucose Prediction by Deduction Learning System | PARK, EVELYN GRACE | — | §102 | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18645166 | METHOD FOR PROMOTING GROWTH OF PLANTS | CHATTERJEE, JAYANTA | 1662 | §103§112 | Final Rejection | 33d | Pending | Apr 24, 2024 |
| 18701598 | HIGH RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETER AND METHODS OF PRODUCING THE SAME | STOFFA, WYATT A | 2881 | §112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18697799 | CELL CULTURE PLATFORMS, METHODS AND USES THEREOF | JOHNSON, KARA D | — | §103§112DP | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18689852 | COMPOUNDS AND THEIR USES FOR TREATING NEURODEGENERATIVE DISEASE | MOU, LIYUAN | 1628 | §103§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18681077 | MICROFLUIDIC MIXER FOR ENHANCED THREE-DIMENSIONAL MIXING | SORKIN, DAVID L | — | §102§103 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18281977 | ANTI- ENOLASE 1 (ENO1) ANTIBODY AND APPLICATIONS THEREOF | STEPHENS, AMELIA CAROLE | 1645 | §112 | Non-Final OA | 70d | Pending | Sep 14, 2023 |
| 18272107 | RECOMBINANT POLYPEPTIDES, CONJUGATES COMPRISING THE SAME, AND USES THEREOF | KAUFMAN, CLAIRE M | 1674 | §112 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18267996 | CELL CULTURE SYSTEMS, METHODS AND USES THEREOF | GONZALES, JOSEPHINE MARIA | 1631 | §101§102§103§112DP | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18266882 | ANTAGONIST OF INTERLEUKIN-17B RECEPTOR (IL-17RB) AND USE THEREOF | BRADLEY, CHRISTINA | 1654 | §101§102§112 | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18116952 | COMPOSITION AND METHOD FOR MODULATING FIBROBLAST GROWTH FACTOR RECEPTOR 3 ACTIVATION | RZECZYCKI, PHILLIP MATTHEW | 1625 | §101§102 | Final Rejection | — | Pending | Mar 03, 2023 |
| 18010647 | ANTIBODIES TO INTERLEUKIN-1BETA AND USES THEREOF | LU, CHENG | 1642 | §112 | Non-Final OA | — | Pending | Dec 15, 2022 |
| 17918947 | OLIGONUCLEOTIDE CONJUGATES AND PREPARATION AND APPLICATIONS THEREOF | PUTTLITZ, KARL J | 1646 | §102§103§112 | Non-Final OA | 8d | Pending | Oct 14, 2022 |
| 17966281 | CELL CULTURE SUBSTRATES, METHODS AND USES THEREOF | JOHNSON, KARA D | 1632 | §103 | Non-Final OA | — | Pending | Oct 14, 2022 |
| 17908585 | METHOD FOR NATURAL KILLER CELL EXPANSION | ROGERS, ERIC JASON | 1638 | §103§112 | Final Rejection | 78d overdue | Pending | Sep 01, 2022 |
| 17756022 | USE OF ANTI-EPCAM ANTIBODIES IN CANCER THERAPY | LU, CHENG | 1642 | §103§112Other | Non-Final OA | — | Pending | May 13, 2022 |
| 17760803 | METHOD FOR IMPROVING GROWTH, STRESS TOLERANCE AND PRODUCTIVITY OF PLANT, AND INCREASING SEED QUALITY OF PLANT | MEADOWS, CHRISTINA L | 1663 | §103 | Non-Final OA | 6d | Pending | Mar 16, 2022 |
| 17630929 | METHODS OF TREATING POMPE DISEASE | CHONG, YONG SOO | 1623 | §103 | Non-Final OA | — | Pending | Jan 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial